ABVC vs CUBE · rev $509.6K vs P/E 25, rev $1.07B
ABVC Biopharma Inc (ABVC) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ABVC currently screens at market cap $35.9M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ABVC and CUBE stock pages for the full models.
Not investment advice.